FI75343B - Foerfarande foer framstaellning av guanylamidiner, vilka aer anvaendbara som hypoglykemiska medel. - Google Patents
Foerfarande foer framstaellning av guanylamidiner, vilka aer anvaendbara som hypoglykemiska medel. Download PDFInfo
- Publication number
- FI75343B FI75343B FI810492A FI810492A FI75343B FI 75343 B FI75343 B FI 75343B FI 810492 A FI810492 A FI 810492A FI 810492 A FI810492 A FI 810492A FI 75343 B FI75343 B FI 75343B
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- hydrochloride
- calculated
- found
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (3)
1. Förfarande för framställning av guanylamidiner med formeln (I), vilka är användbara som hypoglykemiska S medel, Y nh2 (I) 10 i vilken formel R^ och R^ är fenyl; fenyl som substituerats med halogen eller alkoxi med 1-3 kolatomer; bensyl; naftyl; pyridyl; furyl eller tienyl; och Y är 15 /<ch2x Z eller -NR2R3, V<CH2>n/ 20 väri n och m vardera är 1, 2 eller 3, med villkor att summan av n och m är 3-5; Z är CH2, 0, S, NH eller NCH3; och R2 och R3 är n-alkyl med 1-4 kolatomer eller fenyl; kännetecknat därav, att man omsätter en före-25 ning med formeln Y R1Ni^X X 30 med en förening med formeln NH ΙΪ
35 Rt+'^^NH2 II
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12215580 | 1980-02-19 | ||
US06/122,155 US4269837A (en) | 1980-02-19 | 1980-02-19 | Hypoglycemic guanylamidines, compositions and use |
Publications (3)
Publication Number | Publication Date |
---|---|
FI810492L FI810492L (fi) | 1981-08-20 |
FI75343B true FI75343B (fi) | 1988-02-29 |
FI75343C FI75343C (sv) | 1988-06-09 |
Family
ID=22401029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI810492A FI75343C (sv) | 1980-02-19 | 1981-02-18 | Förfarande för framställning av guanylamidiner, vilka är användbara so m hypoglykemiska medel. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4269837A (sv) |
EP (1) | EP0034495B1 (sv) |
JP (1) | JPS56147760A (sv) |
KR (1) | KR840000930B1 (sv) |
AR (1) | AR229350A1 (sv) |
AT (1) | ATE3425T1 (sv) |
AU (1) | AU517843B2 (sv) |
CA (1) | CA1145334A (sv) |
DE (1) | DE3160290D1 (sv) |
DK (1) | DK70881A (sv) |
ES (1) | ES499572A0 (sv) |
FI (1) | FI75343C (sv) |
GR (1) | GR78339B (sv) |
IE (1) | IE50924B1 (sv) |
IL (1) | IL62146A (sv) |
PH (1) | PH15971A (sv) |
PT (1) | PT72516B (sv) |
YU (1) | YU41968B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4404219A (en) * | 1980-03-31 | 1983-09-13 | Pfizer Inc. | Phenylguanidine therapeutic agents |
US5268373A (en) * | 1992-07-28 | 1993-12-07 | Mcneilab, Inc. | Guanidine derivatives, compositions and use |
PT805153E (pt) * | 1996-04-30 | 2002-03-28 | Pfizer | Novos agonistas do receptor muscarinico |
AR008290A1 (es) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH478802A (de) | 1966-09-06 | 1969-09-30 | Sandoz Ag | Verfahren zur Herstellung von Pyrazolderivaten |
CS225804B2 (cs) | 1976-03-19 | 1984-02-13 | Mcneilab Inc | Způsob výroby heterocyklických derivátů guanidinu |
-
1980
- 1980-02-19 US US06/122,155 patent/US4269837A/en not_active Expired - Lifetime
-
1981
- 1981-02-16 JP JP2133581A patent/JPS56147760A/ja active Granted
- 1981-02-16 AR AR284300A patent/AR229350A1/es active
- 1981-02-16 GR GR64154A patent/GR78339B/el unknown
- 1981-02-17 AT AT81300634T patent/ATE3425T1/de not_active IP Right Cessation
- 1981-02-17 CA CA000371114A patent/CA1145334A/en not_active Expired
- 1981-02-17 YU YU398/81A patent/YU41968B/xx unknown
- 1981-02-17 IE IE311/81A patent/IE50924B1/en unknown
- 1981-02-17 EP EP81300634A patent/EP0034495B1/en not_active Expired
- 1981-02-17 PT PT72516A patent/PT72516B/pt unknown
- 1981-02-17 IL IL62146A patent/IL62146A/xx unknown
- 1981-02-17 DE DE8181300634T patent/DE3160290D1/de not_active Expired
- 1981-02-18 AU AU67408/81A patent/AU517843B2/en not_active Ceased
- 1981-02-18 FI FI810492A patent/FI75343C/sv not_active IP Right Cessation
- 1981-02-18 ES ES499572A patent/ES499572A0/es active Granted
- 1981-02-18 DK DK70881A patent/DK70881A/da not_active Application Discontinuation
- 1981-02-18 KR KR1019810000507A patent/KR840000930B1/ko active
- 1981-02-19 PH PH25233A patent/PH15971A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3160290D1 (en) | 1983-07-07 |
EP0034495B1 (en) | 1983-05-18 |
IE810311L (en) | 1981-08-19 |
DK70881A (da) | 1981-08-20 |
GR78339B (sv) | 1984-09-26 |
FI810492L (fi) | 1981-08-20 |
AR229350A1 (es) | 1983-07-29 |
IE50924B1 (en) | 1986-08-20 |
ATE3425T1 (de) | 1983-06-15 |
KR840000930B1 (ko) | 1984-06-29 |
KR830005188A (ko) | 1983-08-03 |
PH15971A (en) | 1983-05-11 |
US4269837A (en) | 1981-05-26 |
PT72516B (en) | 1982-10-21 |
IL62146A (en) | 1984-09-30 |
CA1145334A (en) | 1983-04-26 |
EP0034495A3 (en) | 1982-01-27 |
AU517843B2 (en) | 1981-08-27 |
ES8201541A1 (es) | 1981-12-16 |
IL62146A0 (en) | 1981-03-31 |
FI75343C (sv) | 1988-06-09 |
YU39881A (en) | 1983-09-30 |
JPS6348265B2 (sv) | 1988-09-28 |
EP0034495A2 (en) | 1981-08-26 |
JPS56147760A (en) | 1981-11-16 |
YU41968B (en) | 1988-04-30 |
ES499572A0 (es) | 1981-12-16 |
PT72516A (en) | 1981-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grenda et al. | Novel preparation of benzimidazoles from n-arylamidines. New Synthesis of Thiabendazole1 | |
Klayman et al. | 2-Acetylpyridine thiosemicarbazones. 2. N4, N4-Disubstituted derivatives as potential antimalarial agents | |
US4526896A (en) | Tetrazol-5-yl 2-nitro-3-phenylbenzofurans and antimicrobial use thereof | |
FI75343B (fi) | Foerfarande foer framstaellning av guanylamidiner, vilka aer anvaendbara som hypoglykemiska medel. | |
FI79848C (sv) | Nytt förfarande för framställning av histamin-H2-antagonistiska 3-(ami no eller substituerad amino)-1,2,5-tiadiazoler | |
US2851458A (en) | Diquaternary compounds and the manufacture thereof | |
DK163829B (da) | Fremgangsmaade til fremstilling af 2-guanidino-4-(2-(substitueret-amino)-4-imidazolyl)-thiazoler | |
US3862166A (en) | Certain 3-haloethyl-2-iminothiazolidine | |
JPS6327342B2 (sv) | ||
US4233059A (en) | 1,2,3-Triazole carboxylic acid amides and biocidal compositions containing the same | |
KR870000912B1 (ko) | 디하이드로피리딘 유도체의 제조방법 | |
US3776955A (en) | Pesticidal semicarbazide and biuret derivatives | |
US4281004A (en) | Phenylguanidine therapeutic agents | |
Meijer et al. | Mannich‐type condensation reactions of sulfinic acids with aldehydes and nitrogen bases: Part. VI. The use of ureas, thioureas and thiobenzamide | |
HU186164B (en) | Process for producing 1-bracket-3,4,5-trimethoxy-cinnamyl-bracket closed-4-bracket-amino-carbonyl-ethyl-bracket closed-substituted piperazine derivatives | |
FI69842B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-amino-5-(4-pyridyl)-1,2,4-triazolbaser och farmaceutisktgodtagbara syraadditionssalter daerav | |
DE68907845T2 (de) | Verbrückte bicyclische 4-(4-(3-Benzisothiazolyl)-1-piperazinyl)-butylimide mit antipsychotischer Wirkung. | |
GB2149406A (en) | Substituted ethane diimidamides | |
US4528378A (en) | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity | |
FI77238B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla fenylalkyl(piperazinyl eller homopiperazinyl)alkyltioler eller tiokarbamater. | |
CA1213586A (en) | Substituted pyridopyridiminones | |
US3106553A (en) | Nu-2-propynyl alkylenediamines | |
CA1123852A (en) | Cyclododecane derivatives and a process for the preparation thereof | |
US4029786A (en) | Morpholine derivatives for treating depression | |
SE442510B (sv) | 4-fenyl-tieno/2,3-c/-piperidiner, forfarande for deras framstellning samt anvendning av foreningarna i farmaceutiska beredningar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: PFIZER INC. |